AI-generated summary
The authors review pharmacotherapy for seasonal affective disorder, a condition with depressive episodes in fall and winter. They report that selective serotonin reuptake inhibitors, and possibly compounds with a noradrenergic mechanism, appear to be the treatment of choice. The authors note that relatively few studies have examined medications for this condition and that more placebo-controlled studies are needed.
- Who or what was studied
- Patients with seasonal affective disorder (seasonal depression)
- Limits stated in the abstract
- The abstract notes that comparatively few studies have examined pharmacotherapy and that further placebo-controlled studies are clearly needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.